WASHINGTON, March 10 (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

Medtronic plc MDT recently received the FDA’s approval for the Percept RC Deep Brain Stimulation (“DBS”) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept ...

MINNEAPOLIS, Minnesota — The U.S. Food and Drug Administration approved a Medtronic deep brain stimulation treatment to treat obsessive compulsive disorder – the first deep brain stimulation treatment ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a battery-powered rechargeable deep brain stimulation system for patients with Parkinson’s ...

The technology is designed to adjust therapy in real time based on a patient’s brain activity, potentially improving symptom control, according to a Feb. 24 news release from the company. The ...

A federal judge ruled on Saturday that Kari Lake's leadership of the U.S. Agency for Global Media for much of last year violated federal law, invalidating a sweeping series of actions she took to cut ...

MINNEAPOLIS--(BUSINESS WIRE)-- In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson’s disease, Medtronic DBS Therapy was shown to improve motor function for up to ...

MERRIFIELD, Minn. — Bruce Lunde has never let his age stop him from staying active, so when Parkinson's Disease threatened to slow him down at the age of 81, he decided to take action. Lunde recently ...

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

The US FDA approves Medtronic’s rechargeable deep brain stimulation for patients with movement disorders and epilepsy. The US Food and Drug Administration (FDA) has approved a rechargeable deep brain ...